Skip to main content
. 2021 Nov 7;59(5):285–291. doi: 10.5114/reum.2021.110610

Table I.

Characteristics of the study and control groups, including traditional cardiovascular risk factors

Parameters PsA (1) n = 39 AS (2) n = 40 CG n = 88 p
Female gender, [n (%)] 21 (53.9) 12 (30.0) 42 (47.7) 0.076 (overall test, F)
1 vs. CG: 0.525
2 vs. G: 0.050
1 vs. 2: 0.032
Age [years], mean ±SD 45.1 ±9.6 40.3 ±9.5 42.3 ±8.1 0.056 (overall test, F)
1 vs. CG: 0.240
2 vs. CG: 0.449
1 vs. 2: 0.045
BMI [kg/m<sup>2</sup>], mean ±SD 28.1 ±5.2 24.8 ±4.2 26.4 ±4.3 0.008 (overall test, F)
1 vs. CG: 0.138
2 vs. CG: 0.239
1 vs. 2: 0.005
BSA [m<sup>2</sup>], mean ±SD 1.98 ±0.25 1.91 ±0.23 1.97 ±0.26 0.446 (overall test, F)
1 vs. CG: 0.957
2 vs. CG: 0.548
1 vs. 2: 0.464
Dyslipidemia, [n (%)] 28 (71.8) 19 (47.5) 48 (59.3) 1 vs. CG: 0.182
2 vs. CG: 0.221
1 vs. 2: 0.028
CRP [mg/l] 8.2
(4.0-15.0)
13.5
(5.0–28.5)
2,2
(1.2–2,6)
1 vs. 2: 0.161
1 vs. CG: 0.0017
2 vs. CG: < 0.001
Low physical activity, [n (%)] 27 (69.2) 29 (72.5) NA 1 vs. 2: 0.749
Smoking, [n (%)] 13 (33.3) 17 (42.5) 32 (36.4) 1 vs. 2: 0.401
Family history of cardiovascular diseases, [n (%)] 4 (10.3) 2 (5.0) NA 1 vs. 2: 0.431

AS – ankylosing spondylitis, BMI – body mass index, BSA – body surface area, CG – control group, NA – not available, PsA – psoriatic arthritis.